FindTrial
Sign In

Cost effectiveness of second HIV test in pregnant women

Utility of an additional HIV test near term during pregnancy in strengthening prevention efforts of Mother-to-Child Transmission of HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/12/004183
Enrollment
9000
Registered
2013-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hirabai Cowasji Jehangir Medical Research Institute
Lead Sponsor
Indian Council of Medical Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women in the late third trimester of pregnancy/ women near term who were previously HIV un-infected at least 3 months prior to the enrollment visit 2. Women who are willing to sign/ provide a thumb impression on the written informed consent form

Exclusion criteria

Exclusion criteria: 1. Women who are not willing for a second HIV test in pregnancy

Design outcomes

Primary

MeasureTime frame
Number of new HIV infections detected in pregnant women during the 2nd HIV test in pregnancy who were HIV negative during the first test (in pregnancy)Timepoint: beyond 34 weeks of pregnancy—

Secondary

MeasureTime frame
new HIV infection among pregnant women who were HIV negative during pregnancyTimepoint: after 34 weeks—

Countries

India

Contacts

Public ContactDr Smita Joshi

HCJMRI

smitanjoshi@gmail.com09881132506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 4, 2026